Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdvanSix (ASIX) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for AdvanSix (ASIX) over the last 11 years, with Q3 2025 value amounting to $262000.0.

  • AdvanSix's Gains from Investment Securities fell 8869.23% to $262000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 2944.62%. This contributed to the annual value of $9.2 million for FY2024, which is 16079.55% up from last year.
  • According to the latest figures from Q3 2025, AdvanSix's Gains from Investment Securities is $262000.0, which was down 8869.23% from $3.2 million recorded in Q2 2025.
  • AdvanSix's Gains from Investment Securities' 5-year high stood at $3.2 million during Q2 2025, with a 5-year trough of -$2.7 million in Q4 2021.
  • Moreover, its 5-year median value for Gains from Investment Securities was $1.0 million (2023), whereas its average is $1.0 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first plummeted by 103588.85% in 2021, then skyrocketed by 52948.21% in 2022.
  • AdvanSix's Gains from Investment Securities (Quarter) stood at -$2.7 million in 2021, then surged by 129.08% to $781000.0 in 2022, then surged by 42.89% to $1.1 million in 2023, then surged by 180.2% to $3.1 million in 2024, then crashed by 91.62% to $262000.0 in 2025.
  • Its Gains from Investment Securities stands at $262000.0 for Q3 2025, versus $3.2 million for Q2 2025 and $2.7 million for Q1 2025.